Company Filing History:
3 out of 2,943 
3 out of 1,151 
Years Active: 2020-2024
Title: Meredith Suzanne Eno: Innovator in GCN2 Inhibitors
Introduction
Meredith Suzanne Eno is a prominent inventor based in Brighton, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of GCN2 inhibitors. With a total of three patents to her name, her work has the potential to impact the treatment of various disorders, including cancer.
Latest Patents
Among her latest patents, Meredith has developed compounds and compositions that inhibit General amino acid Control Non-derepressible 2 kinase (GCN2). These inventions provide methods for using these compounds to treat various disorders. The innovative nature of her work lies in the potential applications of these inhibitors in medical treatments.
Career Highlights
Meredith has worked with notable companies in the pharmaceutical industry, including Merck Patent GmbH and Vertex Pharmaceuticals, Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.
Collaborations
Throughout her career, Meredith has collaborated with talented individuals such as Matthew Bleich and Jean-Damien Charrier. These partnerships have further enhanced her research and development efforts.
Conclusion
Meredith Suzanne Eno is a trailblazer in the field of GCN2 inhibitors, with a promising career marked by her innovative patents and collaborations. Her work continues to pave the way for advancements in medical treatments.